Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab?

Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial

(2020) Alberto Briganti et al.   EUROPEAN UROLOGY

Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab

(2020) Ashley M. Hopkins et al.   EUROPEAN UROLOGY

Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer

(2020) Marco Bandini et al.   JNCI-Journal of the National Cancer Institute

Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆

(2020) M. Bandini et al.   ANNALS OF ONCOLOGY

Infections and Immunotherapy in Lung Cancer: A Bad Relationship?

(2020) Lorenzo Belluomini et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The microbiome, cancer, and cancer therapy

(2019) Beth A. Helmink et al.   NATURE MEDICINE

Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer

(2019) David J. Pinato et al.   JAMA Oncology

Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies

(2019) Andrea Necchi et al.   EUROPEAN UROLOGY

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

(2019) Thomas Powles et al.   NATURE MEDICINE

The effect of antibiotics on the composition of the intestinal microbiota - a systematic review

(2019) Petra Zimmermann et al.   JOURNAL OF INFECTION

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer

(2018) L Derosa et al.   ANNALS OF ONCOLOGY

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

(2013) S. Viaud et al.   SCIENCE